Sophia Thy
Papers
2
Total Citations
10
H-Index
2
About
Sophia Thy is a pioneering urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for testicular cancer. Her major contributions lie in the development and validation of robot-assisted retroperitoneal lymph node dissection (R-RPLND) and sentinel node biopsy, challenging the traditional open surgery paradigm. Thy’s landmark matched-pair analysis (2025, 7 citations) demonstrated that R-RPLND offers comparable peri-operative and oncological safety to open surgery, providing critical evidence for its adoption. She is also the lead investigator of the RAISN trial (2024, 3 citations), which investigates robot-assisted indocyanine green-guided sentinel node biopsy for detecting occult metastases in clinical stage I germ cell tumors—a novel technique that could spare patients unnecessary lymphadenectomy. Though early in her citation impact, Thy’s work is highly influential in reshaping testicular cancer management, reducing morbidity while maintaining oncologic rigor. Her research bridges surgical innovation and patient-centered outcomes, positioning her as a rising leader in robotic urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2